The blood-brain barrier (BBB) GLUT1 glucose transporter is abundant in brain, and localized to the capillary endothelia. In vitro studies of other isoforms of the glucose transporter have demonstrated that rapid up-regulation of glucose transport is achieved through translocation of transporter proteins from intracellular sites to the external cell membrane, i.e., transporter recruitment. Down-regulation is characterized by relocation of the transporters to internal sites. It is proposed to experimentally manipulate BBB glucose transporter in vivo (to confirm that rapid up- or down regulation has been achieved), and then study the localization patterns of the GLUT1 transporter using immunogold electron microscopic methods. A unique feature of BBB endothelia is the apparent asymmetric distribution of GLUT1 transporters; ablumenal membranes have a 3-4 fold greater number of transporters than the lumenal membrane, and relatively short distances (300-500 nm) separate these endothelial surfaces. Because the lumenal capillary membrane is believed to be the site where rate-limitation of BBB glucose transport may occur, we also propose to test the hypothesis that rapid up-and down-regulation in these endothelia may not only involve translocation of cytoplasmic transporter proteins, but also movement from the ablumenal to lumenal membrane across relatively short distances. Using membrane-impermeant agents, site-selective in vivo experimental manipulation of lumenal membrane GLUT1 transporters is planned. It is anticipated that this work will provide insights into the cellular mechanisms of BBB glucose transport, and define transporter responses in anoxia, brain injury, seizures and in brain tumors.

Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Hu, Jinwei; Yuan, Xiangpeng; Ko, MinHee K et al. (2007) Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model. Mol Cancer 6:22
Black, Keith L; Ningaraj, Nagendra S (2004) Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor. Cancer Control 11:165-73
Ningaraj, Nagendra S; Rao, Mamatha K; Black, Keith L (2003) Adenosine 5'-triphosphate-sensitive potassium channel-mediated blood-brain tumor barrier permeability increase in a rat brain tumor model. Cancer Res 63:8899-911
Ningaraj, Nagendra S; Rao, Mamatha; Black, Keith L (2003) Calcium-dependent potassium channels as a target protein for modulation of the blood-brain tumor barrier. Drug News Perspect 16:291-8
Ningaraj, Nagendra S; Rao, Mamatha; Hashizume, Kazuhiro et al. (2002) Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels. J Pharmacol Exp Ther 301:838-51
Liu, Y; Hashizume, K; Samoto, K et al. (2001) Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma. Neurol Res 23:631-40
Liu, Y; Hashizume, K; Chen, Z et al. (2001) Correlation between bradykinin-induced blood-tumor barrier permeability and B2 receptor expression in experimental brain tumors. Neurol Res 23:379-87
Cornford, E M; Nguyen, E V; Landaw, E M (2000) Acute upregulation of blood-brain barrier glucose transporter activity in seizures. Am J Physiol Heart Circ Physiol 279:H1346-54
Golden, P L; Pardridge, W M (2000) Brain microvascular P-glycoprotein and a revised model of multidrug resistance in brain. Cell Mol Neurobiol 20:165-81
Boado, R J; Li, J Y; Pardridge, W M (2000) Selective Lutheran glycoprotein gene expression at the blood-brain barrier in normal brain and in human brain tumors. J Cereb Blood Flow Metab 20:1096-102

Showing the most recent 10 out of 108 publications